Virtual Medicinal Product (VMP) - Rivastigmine 13.3mg/24hours transdermal patches
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Rivastigmine 13.3mg/24hours transdermal patches | Start Date 01-05-2013 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- patch
- Unit Dose UOM
- patch
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Transdermal
- Form
- Transdermal patch
- Ontology Form/Route
- patch.transdermal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- N06DA03
- BNF Codes
-
- BNF code 04110000
| Code | Start Date | End Date |
|---|---|---|
| 22403511000001106 | 01-05-2013 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Rivastigmine | Based on Ingredient Substance | 13.3 mg | 24 hour |
Name
Rivastigmine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
13.3
Strength and UOM (Dmr)
24
Parent Products
-
VTMRivastigmine
-
VMP(Current) Rivastigmine 13.3mg/24hours transder...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 30 patch | 7797 | Part VIIIA Category C |